サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339257

ナノメディシン市場、シェア、規模、動向、産業分析レポート：用途別、適応症別、分子タイプ別、地域別、セグメント別予測、2023年～2032年

Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ナノメディシン市場、シェア、規模、動向、産業分析レポート：用途別、適応症別、分子タイプ別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のナノメディシン市場規模は2032年までに5,377億5,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

がんや心血管疾患などの慢性疾患の蔓延が、ナノメディシンの需要を牽引しています。高齢化が進み、高血圧や肥満などの疾患を持つ患者が増加する中、革新的で的を絞った治療アプローチの必要性が高まっています。例えば、米国がん協会によると、2022年には米国だけで190万人のがん患者が新たに発生し、60万9360人ががん関連で死亡すると推定されています。このことは、こうしたヘルスケアの課題に対処するために、ナノメディシンを含む先進的な治療法が緊急に必要であることを浮き彫りにしています。

ナノメディシンは、ターゲットを絞ったドラッグデリバリー、イメージング技術の向上、個別化医療のアプローチを可能にし、治療成果を高める。新しいドラッグデリバリー技術の出現も、ナノメディシン産業の拡大に寄与しています。ナノ粒子、ナノキャリア、その他のナノスケールのドラッグデリバリーシステムは、バイオアベイラビリティの向上、放出制御、副作用の軽減などの利点を提供します。ドラッグデリバリー技術におけるこうした進歩は、製薬会社やヘルスケアプロバイダーの注目と投資を集めています。

政府の資金援助と支援は、ナノメディシン市場を前進させる上で極めて重要です。世界各国の政府は、ヘルスケアに革命をもたらすナノメディシンの可能性を認識しており、ナノメディシン製品の開発と商業化を促進するため、財政支援、研究助成、規制支援を提供しています。政府の資金援助や支援イニシアチブの増加は、学界、産業界、研究機関の連携を促進し、市場成長にプラスの影響を与えると予想されます。例えば、2022年8月、韓国のライフサイエンス・ファンドはセンダ・バイオサイエンシズに1,400万米ドル以上の投資を発表しました。このような投資は、有望な成長機会を示し、ナノメディシン産業の将来に対する自信を示すものです。

過去数十年の間に米国食品医薬品局（FDA）により約100のナノメディシン・アプリケーションとデバイスが認可されたことは、ナノテクノロジーの医学的可能性に対する関心の高まりに大きく貢献しています。規制当局によるこの検証は、ナノメディシンへの信頼を高め、この分野へのさらなる投資、研究開発を刺激しました。医療治療と療法の進歩におけるナノテクノロジーの役割に対する認識の高まりは、医療分野における画期的な進歩と見なされ、市場成長の原動力となっています。

ナノメディシン市場レポートハイライト

近代的な取引チャネル部門は、食料品チェーン、ミニマート、ハイパーマーケットのような大手企業が含まれるため、予測期間中に大きなCAGRで成長すると予測されます。

スポーツ用品店は最大の収益シェアを占め、これはスポーツ用品店における様々なスノースクーターの利用可能性の高まりによって加速しています。

アジア太平洋地域は、スノースクーターの開発だけでなく、スノースポーツ活動の高まりを理由に、予測期間中にかなりのCAGRで成長することが期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のナノメディシン市場に関する洞察

  • ナノメディシン市場- 分子タイプのスナップショット
  • ナノメディシン市場力学
    • 促進要因と機会
      • 再生可能エネルギー源の需要の増加
      • 電力消費需要の増加
    • 抑制要因と課題
      • 初期費用が高い
  • PESTEL分析
  • ナノメディシン市場の分子種の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のナノメディシン市場、適応症別

  • 主な調査結果
  • イントロダクション
  • 臨床腫瘍学
  • 感染症
  • 臨床循環器学
  • 整形外科
  • その他

第6章 世界のナノメディシン市場、用途別

  • 主な調査結果
  • イントロダクション
  • 治療学
  • 体外診断
  • ドラッグデリバリー
  • 生体内イメージング
  • インプラント

第7章 世界のナノメディシン市場、分子タイプ別

  • 主な調査結果
  • イントロダクション
  • ナノ粒子
  • ナノシェル
  • ナノチューブ
  • ナノデバイス

第8章 世界のナノメディシン市場、地域別

  • 主な調査結果
  • イントロダクション
    • ナノメディシン市場評価、地域別、2019-2032年
  • ナノメディシン市場-北米
    • 北米：適応症別ナノメディシン市場、2019-2032年
    • 北米：分子タイプ別ナノメディシン市場、2019-2032年
    • 北米：ナノメディシン市場、用途別、2019-2032年
    • ナノメディシン市場-米国
    • ナノメディシン市場- カナダ
  • ナノメディシン市場- 欧州
    • 欧州：ナノメディシン市場、適応症別、2019～2032年
    • 欧州：ナノメディシン市場、分子タイプ別、2019～2032年
    • 欧州：ナノメディシン市場、用途別、2019～2032年
    • ナノメディシン市場- 英国
    • ナノメディシン市場- フランス
    • ナノメディシン市場- ドイツ
    • ナノメディシン市場- イタリア
    • ナノメディシン市場- スペイン
    • ナノメディシン市場- オランダ
    • ナノメディシン市場- ロシア
  • ナノメディシン市場- アジア太平洋
    • アジア太平洋：適応症別ナノメディシン市場、2019～2032年
    • アジア太平洋：ナノメディシン市場、分子タイプ別、2019～2032年
    • アジア太平洋：ナノメディシン市場、用途別、2019～2032年
    • ナノメディシン市場- 中国
    • ナノメディシン市場- インド
    • ナノメディシン市場- マレーシア
    • ナノメディシン市場- 日本
    • ナノメディシン市場- インドネシア
    • ナノメディシン市場- 韓国
  • ナノメディシン市場-中東およびアフリカ
    • 中東およびアフリカ：ナノメディシン市場、適応症別、2019～2032年
    • 中東およびアフリカ：ナノメディシン市場、分子タイプ別、2019～2032年
    • 中東およびアフリカ：ナノメディシン市場、用途別、2019～2032年
    • ナノメディシン市場- サウジアラビア
    • ナノメディシン市場- アラブ首長国連邦
    • ナノメディシン市場- イスラエル
    • ナノメディシン市場- 南アフリカ
  • ナノメディシン市場-ラテンアメリカ
    • ラテンアメリカ：ナノメディシン市場、適応症別、2019-2032年
    • ラテンアメリカ：ナノメディシン市場、分子タイプ別、2019-2032
    • ラテンアメリカ：ナノメディシン市場、用途別、2019-2032年
    • ナノメディシン市場- メキシコ
    • ナノメディシン市場- ブラジル
    • ナノメディシン市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • GE Healthcare
  • Abbott Laboratories
  • CombiMatrix Corporation
  • Celgene
  • Nanospectra Biosciences
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Merck
  • Pfizer
  • Teva Pharmaceutical
  • Arrowhead Pharmaceuticals
図表

List of Tables

  • Table 1 Global Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 2 Global Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 4 Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 6 North America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 8 U.S.: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 Canada: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 14 Europe: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 17 UK: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 18 UK: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 20 France: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 21 France: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 26 Italy: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 29 Spain: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Russia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 41 China: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 42 China: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 44 India: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 45 India: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 50 Japan: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 56 South Korea: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 65 UAE: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 68 Israel: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 South Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 74 Latin America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 77 Mexico: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 80 Brazil: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Argentina: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Waste to Energy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Waste to Energy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Waste Type
  • Figure 9. Global Waste to Energy Market, by Waste Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Waste to Energy Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 12. Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Waste to Energy Market
目次
Product Code: PM3637

The global nanomedicine market size is expected to reach USD 537.75 billion by 2032, according to a new study by Polaris Market Research. The report "Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The prevalence of chronic diseases, including cancer and cardiovascular diseases, is driving the demand for nanomedicine. With an aging population and an increase in patients with conditions such as high blood pressure and obesity, the need for innovative and targeted treatment approaches has become more critical. For example, according to the American Cancer Society, in 2022, it was estimated that there would be 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States alone. This highlights the urgent need for advanced therapies, including nanomedicine, to address these healthcare challenges.

Nanomedicine enables targeted drug delivery, improved imaging techniques, and personalized medicine approaches, enhancing treatment outcomes. The emergence of novel drug-delivery technologies also contributes to the nanomedicine industry's expansion. Nanoparticles, nanocarriers, and other nanoscale drug delivery systems offer advantages such as improved bioavailability, controlled release, and reduced side effects. These advancements in drug delivery technology have attracted attention and investment from pharmaceutical companies and healthcare providers.

Government funding and support are crucial in driving the nanomedicine market forward. Governments worldwide recognize the potential of nanomedicine in revolutionizing healthcare and are providing financial assistance, research grants, and regulatory support to encourage the development and commercialization of nanomedicine products. The increase in government funding and support initiatives is anticipated to positively impact market growth, fostering collaboration between academia, industry, and research institutions. For instance, in August 2022, South Korea's Life Science Fund announced an investment of over USD 14 Mn in Senda Biosciences. Such investments indicate promising growth opportunities and signify confidence in the future of the nanomedicine industry.

The authorization of approximately 100 nanomedicine applications and devices by the US Food and Drug Administration (FDA) over the past few decades has significantly contributed to the increasing interest in nanotechnology's medical potential. This validation by regulatory authorities has boosted confidence in nanomedicine and stimulated further investment, research, and development in the field. The growing recognition of nanotechnology's role in advancing medical treatments and therapies is considered a breakthrough in the medical field, driving market growth.

Nanomedicine Market Report Highlights

The modern trade channels segment is anticipated to grow at a significant CAGR over the forecast period owing to they include bigger players like grocery chains, mini-marts, and hypermarkets.

Sports variety stores accounted for largest revenue share which is accelerated by the rising availability of various snow scooters in the sports stores.

Asia-Pacific is expected to grow at a considerable CAGR over the projected period on account of the rising snow sports activities as well as the development of snow scooters.

The global players include: Crayon Motors, Jiangsu Youmota Technology, NSG Products, Railz LLC, Shanghai Puyi Industrial, Lakeside Collection, Eretic Inc., and Wuxi Copower Technology.

Polaris Market Research has segmented the nanomedicine market report based on application, indication, molecule type, and region:

Nanomedicine, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Therapeutics
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

Nanomedicine, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

Nanomedicine, Molecule Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Nanoparticles
  • Metal & Metal Oxide Nanoparticles
  • Liposomes
  • Polymers & Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

Nanomedicine, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Nanomedicine Market Insights

  • 4.1. Nanomedicine Market - Molecule Type Snapshot
  • 4.2. Nanomedicine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in demand for renewable sources of energy
      • 4.2.1.2. Rise in demand for electricity consumption
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High initial costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nanomedicine Market Molecule Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nanomedicine Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  • 5.3. Clinical Oncology
    • 5.3.1. Global Nanomedicine Market, by Clinical Oncology, by Region, 2019-2032 (USD Billion)
  • 5.4. Infectious diseases
    • 5.4.1. Global Nanomedicine Market, by Infectious diseases, by Region, 2019-2032 (USD Billion)
  • 5.5. Clinical Cardiology
    • 5.5.1. Global Nanomedicine Market, by Clinical Cardiology, by Region, 2019-2032 (USD Billion)
  • 5.6. Orthopedics
    • 5.6.1. Global Nanomedicine Market, by Orthopedics, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Nanomedicine Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Nanomedicine Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nanomedicine Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Therapeutics
    • 6.3.1. Global Nanomedicine Market, by Therapeutics, by Region, 2019-2032 (USD Billion)
  • 6.4. in-vitro Diagnostics
    • 6.4.1. Global Nanomedicine Market, by in-vitro Diagnostics, by Region, 2019-2032 (USD Billion)
  • 6.5. Drug Delivery
    • 6.5.1. Global Nanomedicine Market, by Drug Delivery, by Region, 2019-2032 (USD Billion)
  • 6.6. In-vivo Imaging
    • 6.6.1. Global Nanomedicine Market, by In-vivo Imaging, by Region, 2019-2032 (USD Billion)
  • 6.7. Implants
    • 6.7.1. Global Nanomedicine Market, by Implants, by Region, 2019-2032 (USD Billion)

7. Global Nanomedicine Market, by Molecule Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  • 7.3. Nanoparticles
    • 7.3.1. Global Nanomedicine Market, by Nanoparticles, By Region, 2019-2032 (USD Billion)
    • 7.3.2. Metal & Metal Oxide Nanoparticles
      • 7.3.2.1. Global Nanomedicine Market, by Metal & Metal Oxide Nanoparticles, By Region, 2019-2032 (USD Billion)
    • 7.3.3. Liposomes
      • 7.3.3.1. Global Nanomedicine Market, by Liposomes, By Region, 2019-2032 (USD Billion)
    • 7.3.4. Polymers & polymer drug conjugates
      • 7.3.4.1. Global Nanomedicine Market, by Polymers & polymer drug conjugates, By Region, 2019-2032 (USD Billion)
    • 7.3.5. Hydrogel Nanoparticles
      • 7.3.5.1. Global Nanomedicine Market, by Hydrogel Nanoparticles, By Region, 2019-2032 (USD Billion)
    • 7.3.6. Dendrimers
      • 7.3.6.1. Global Nanomedicine Market, by Dendrimers, By Region, 2019-2032 (USD Billion)
    • 7.3.7. Inorganic Nanoparticles
      • 7.3.7.1. Global Nanomedicine Market, by Inorganic Nanoparticles, By Region, 2019-2032 (USD Billion)
  • 7.4. Nanoshells
    • 7.4.1. Global Nanomedicine Market, by Nanoshells, By Region, 2019-2032 (USD Billion)
  • 7.5. Nanotubes
    • 7.5.1. Global Nanomedicine Market, by Nanotubes, By Region, 2019-2032 (USD Billion)
  • 7.6. Nanodevices
    • 7.6.1. Global Nanomedicine Market, by Nanodevices, By Region, 2019-2032 (USD Billion)

8. Global Nanomedicine Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Nanomedicine Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Nanomedicine Market - North America
    • 8.3.1. North America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
    • 8.3.2. North America: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Nanomedicine Market - U.S.
      • 8.3.4.1. U.S.: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Nanomedicine Market - Canada
      • 8.3.5.1. Canada: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Nanomedicine Market - Europe
    • 8.4.1. Europe: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Nanomedicine Market - UK
      • 8.4.4.1. UK: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Nanomedicine Market - France
      • 8.4.5.1. France: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Nanomedicine Market - Germany
      • 8.4.6.1. Germany: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Nanomedicine Market - Italy
      • 8.4.7.1. Italy: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Nanomedicine Market - Spain
      • 8.4.8.1. Spain: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Nanomedicine Market - Netherlands
      • 8.4.9.1. Netherlands: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Nanomedicine Market - Russia
      • 8.4.10.1. Russia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Nanomedicine Market - Asia Pacific
    • 8.5.1. Asia Pacific: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Nanomedicine Market - China
      • 8.5.4.1. China: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Nanomedicine Market - India
      • 8.5.5.1. India: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Nanomedicine Market - Malaysia
      • 8.5.6.1. Malaysia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Nanomedicine Market - Japan
      • 8.5.7.1. Japan: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Nanomedicine Market - Indonesia
      • 8.5.8.1. Indonesia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Nanomedicine Market - South Korea
      • 8.5.9.1. South Korea: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Nanomedicine Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Nanomedicine Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Nanomedicine Market - UAE
      • 8.6.5.1. UAE: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Nanomedicine Market - Israel
      • 8.6.6.1. Israel: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Nanomedicine Market - South Africa
      • 8.6.7.1. South Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Nanomedicine Market - Latin America
    • 8.7.1. Latin America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Nanomedicine Market - Mexico
      • 8.7.4.1. Mexico: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Nanomedicine Market - Brazil
      • 8.7.5.1. Brazil: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Nanomedicine Market - Argentina
      • 8.7.6.1. Argentina: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Nanomedicine Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. GE Healthcare
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CombiMatrix Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Celgene
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Nanospectra Biosciences
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pfizer
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teva Pharmaceutical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Arrowhead Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development